RU2013134133A - Применение содержащих лактоферрин питательных композиций при поддержании устойчивости к заболеваниям и состояниям - Google Patents
Применение содержащих лактоферрин питательных композиций при поддержании устойчивости к заболеваниям и состояниям Download PDFInfo
- Publication number
- RU2013134133A RU2013134133A RU2013134133/10A RU2013134133A RU2013134133A RU 2013134133 A RU2013134133 A RU 2013134133A RU 2013134133/10 A RU2013134133/10 A RU 2013134133/10A RU 2013134133 A RU2013134133 A RU 2013134133A RU 2013134133 A RU2013134133 A RU 2013134133A
- Authority
- RU
- Russia
- Prior art keywords
- lactoferrin
- kcal
- source
- coli
- disease
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract 10
- 201000010099 disease Diseases 0.000 title claims abstract 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract 9
- 235000016709 nutrition Nutrition 0.000 title claims abstract 9
- 238000000034 method Methods 0.000 claims abstract 24
- 102000010445 Lactoferrin Human genes 0.000 claims abstract 15
- 108010063045 Lactoferrin Proteins 0.000 claims abstract 15
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims abstract 15
- 229940078795 lactoferrin Drugs 0.000 claims abstract 15
- 235000021242 lactoferrin Nutrition 0.000 claims abstract 15
- 241000588724 Escherichia coli Species 0.000 claims abstract 8
- 101000798114 Homo sapiens Lactotransferrin Proteins 0.000 claims abstract 5
- 102000050459 human LTF Human genes 0.000 claims abstract 5
- 239000003925 fat Substances 0.000 claims abstract 4
- 150000002632 lipids Chemical class 0.000 claims abstract 4
- 235000018102 proteins Nutrition 0.000 claims abstract 4
- 102000004169 proteins and genes Human genes 0.000 claims abstract 4
- 108090000623 proteins and genes Proteins 0.000 claims abstract 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims abstract 3
- 239000012634 fragment Substances 0.000 claims abstract 3
- 241000606768 Haemophilus influenzae Species 0.000 claims abstract 2
- 241000282412 Homo Species 0.000 claims abstract 2
- 241001263478 Norovirus Species 0.000 claims abstract 2
- 241000725643 Respiratory syncytial virus Species 0.000 claims abstract 2
- 241000702670 Rotavirus Species 0.000 claims abstract 2
- 241000607142 Salmonella Species 0.000 claims abstract 2
- 108010079723 Shiga Toxin Proteins 0.000 claims abstract 2
- 241000607762 Shigella flexneri Species 0.000 claims abstract 2
- 208000036142 Viral infection Diseases 0.000 claims abstract 2
- 230000000369 enteropathogenic effect Effects 0.000 claims abstract 2
- 230000000688 enterotoxigenic effect Effects 0.000 claims abstract 2
- 244000052769 pathogen Species 0.000 claims abstract 2
- 230000001717 pathogenic effect Effects 0.000 claims abstract 2
- 210000002345 respiratory system Anatomy 0.000 claims abstract 2
- 241000701161 unidentified adenovirus Species 0.000 claims abstract 2
- 230000009385 viral infection Effects 0.000 claims abstract 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 4
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims 2
- 229910052742 iron Inorganic materials 0.000 claims 2
- 229920001100 Polydextrose Polymers 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims 1
- 150000003271 galactooligosaccharides Chemical class 0.000 claims 1
- 238000009928 pasteurization Methods 0.000 claims 1
- 229940035035 polydextrose Drugs 0.000 claims 1
- 235000013856 polydextrose Nutrition 0.000 claims 1
- 239000001259 polydextrose Substances 0.000 claims 1
- 235000013406 prebiotics Nutrition 0.000 claims 1
- 239000002966 varnish Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Pediatric Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/980,833 US20120171164A1 (en) | 2010-12-29 | 2010-12-29 | Use of nutritional compositions including lactoferrin in supporting resistance to viral respiratory tract infections |
| US12/980,825 | 2010-12-29 | ||
| US12/980,825 US20120172288A1 (en) | 2010-12-29 | 2010-12-29 | Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions |
| US12/980,833 | 2010-12-29 | ||
| PCT/US2011/065229 WO2012091945A1 (en) | 2010-12-29 | 2011-12-15 | Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2013134133A true RU2013134133A (ru) | 2015-02-10 |
Family
ID=45507878
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013134133/10A RU2013134133A (ru) | 2010-12-29 | 2011-12-15 | Применение содержащих лактоферрин питательных композиций при поддержании устойчивости к заболеваниям и состояниям |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP2658389A1 (es) |
| CN (2) | CN103429092A (es) |
| BR (1) | BR112013015458A2 (es) |
| CA (1) | CA2823018A1 (es) |
| EC (1) | ECSP13012799A (es) |
| HK (1) | HK1250608A1 (es) |
| MX (1) | MX2013005943A (es) |
| PE (1) | PE20141826A1 (es) |
| RU (1) | RU2013134133A (es) |
| SG (1) | SG190780A1 (es) |
| TW (1) | TW201306760A (es) |
| WO (1) | WO2012091945A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20122152A1 (it) | 2012-12-17 | 2014-06-18 | Progine Farmaceutici S R L | Composizione per uso topico. |
| US9609888B2 (en) * | 2013-07-31 | 2017-04-04 | Mead Johnson Nutrition Company | Nutritional compositions containing synergistic combination and uses thereof |
| US20160015068A1 (en) * | 2014-07-16 | 2016-01-21 | Mead Johnson Nutrition Company | Nutritional formulas containing oil blends and uses thereof |
| EP2992894A1 (en) | 2014-09-05 | 2016-03-09 | Progine Farmaceutici Srl | Vaginal formulations for preventing and treating vaginal and cervico-vaginal infections |
| IT201600128713A1 (it) * | 2016-12-20 | 2018-06-20 | Frima Res Srls | Composizione nel trattamento dell'anemia infiammatoria o da flogosi da malattia cronica |
| WO2022091023A1 (en) * | 2020-11-02 | 2022-05-05 | Apharm Srl | Combination of active ingredients, compositions containing it and their use to sustain and strengthen the immune system |
| CN115886073A (zh) * | 2022-04-01 | 2023-04-04 | 北京三元食品股份有限公司 | 一种发酵乳 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE61701B1 (en) | 1986-07-17 | 1994-11-30 | Morinaga Milk Industry Co Ltd | Process for producing bovine lactoferrin in high purity |
| US5407957A (en) | 1990-02-13 | 1995-04-18 | Martek Corporation | Production of docosahexaenoic acid by dinoflagellates |
| EP1787532A3 (en) | 1991-01-24 | 2010-03-31 | Martek Biosciences Corporation | Microbial oil mixtures and uses thereof |
| US5374567A (en) | 1993-05-20 | 1994-12-20 | The United States Of America As Represented By The Secretary Of The Navy | Operational amplifier using bipolar junction transistors in silicon-on-sapphire |
| US5861491A (en) | 1994-02-16 | 1999-01-19 | Pharming B.V. | Isolation of lactoferrin from milk |
| WO2003073866A1 (en) | 2002-03-07 | 2003-09-12 | Upfront Chromatography A/S | A process of isolating lactoferrin |
| CN101247823A (zh) * | 2005-05-05 | 2008-08-20 | 布里斯托尔-迈尔斯斯奎布公司 | 牛乳铁蛋白在制备抑制细菌生长的药物中的用途 |
| US20070191264A1 (en) * | 2005-05-05 | 2007-08-16 | Bristol-Myers Squibb Company, A Delaware Corporation | Methods for inhibiting the growth of bacteria |
| US7572474B2 (en) | 2005-06-01 | 2009-08-11 | Mead Johnson Nutrition Company | Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants |
| JP2009513572A (ja) * | 2005-09-28 | 2009-04-02 | ベントリア バイオサイエンス | 腸管障害及び／又は下痢用の経口組成物 |
| US20080003329A1 (en) * | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Enriched infant formulas |
| WO2008047391A1 (en) * | 2006-10-17 | 2008-04-24 | S.I.F.Fr.A. Farmaceutici Srl | Nutriceutic composition comprising lactoferrin and proteasic probiotics |
| CN101130079A (zh) * | 2007-07-19 | 2008-02-27 | 浙江省中医药研究院 | 乳铁蛋白在制备防治人轮状病毒所致疾病的药物中的应用 |
| WO2009068549A1 (en) * | 2007-11-26 | 2009-06-04 | Nestec S.A. | Age-tailored nutrition system for infants |
| ITRM20080163A1 (it) * | 2008-03-26 | 2009-09-27 | Maurizio Acri | Uso della lattoferrina per la prevenzione delle sepsi neonatali in neonati prematuri |
| US20120219526A1 (en) * | 2009-10-29 | 2012-08-30 | Nestec S.A. | Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof |
-
2011
- 2011-12-15 CA CA2823018A patent/CA2823018A1/en not_active Abandoned
- 2011-12-15 WO PCT/US2011/065229 patent/WO2012091945A1/en active Application Filing
- 2011-12-15 CN CN2011800627084A patent/CN103429092A/zh active Pending
- 2011-12-15 SG SG2013035936A patent/SG190780A1/en unknown
- 2011-12-15 PE PE2013001479A patent/PE20141826A1/es not_active Application Discontinuation
- 2011-12-15 RU RU2013134133/10A patent/RU2013134133A/ru not_active Application Discontinuation
- 2011-12-15 BR BR112013015458A patent/BR112013015458A2/pt not_active IP Right Cessation
- 2011-12-15 EP EP11810939.6A patent/EP2658389A1/en not_active Ceased
- 2011-12-15 CN CN201711129504.3A patent/CN107668721A/zh active Pending
- 2011-12-15 MX MX2013005943A patent/MX2013005943A/es unknown
- 2011-12-22 TW TW100148027A patent/TW201306760A/zh unknown
-
2013
- 2013-07-29 EC ECSP13012799 patent/ECSP13012799A/es unknown
-
2018
- 2018-08-06 HK HK18110050.6A patent/HK1250608A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2012091945A1 (en) | 2012-07-05 |
| TW201306760A (zh) | 2013-02-16 |
| CA2823018A1 (en) | 2012-07-05 |
| CN103429092A (zh) | 2013-12-04 |
| HK1250608A1 (zh) | 2019-01-11 |
| CN107668721A (zh) | 2018-02-09 |
| SG190780A1 (en) | 2013-07-31 |
| EP2658389A1 (en) | 2013-11-06 |
| ECSP13012799A (es) | 2013-10-31 |
| PE20141826A1 (es) | 2014-12-17 |
| BR112013015458A2 (pt) | 2016-08-09 |
| MX2013005943A (es) | 2013-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2013134133A (ru) | Применение содержащих лактоферрин питательных композиций при поддержании устойчивости к заболеваниям и состояниям | |
| ES2558960T3 (es) | Composición nutricional para la prevención de infecciones | |
| DK2164349T3 (en) | protein-FORMULA | |
| Wong et al. | Bovine colostrum enhances natural killer cell activity and immune response in a mouse model of influenza infection and mediates intestinal immunity through toll-like receptors 2 and 4 | |
| Kassem | Future challenges of whey proteins | |
| BRPI0610784A2 (pt) | uso de oligossacarìdeos ácidos e neutros | |
| BRPI0610786A2 (pt) | uso de um ou mais oligossacarìdeos ácidos e neutros, e cisteìna e/ou fonte de cisteìna, e, composição alimentìcia | |
| JP7434155B2 (ja) | オートファジーの誘導のためにオートファジー誘導因子と高タンパク質との組み合わせを使用する組成物及び方法 | |
| US11559539B2 (en) | Human milk oligosaccharide for improving immune fitness | |
| Ashraf et al. | Nutraceutical and health-promoting potential of lactoferrin, an iron-binding protein in human and animal: current knowledge | |
| RU2015122497A (ru) | Содержащие лактоферрин питательные композиции на основе молока и их применение | |
| JP2022536032A (ja) | オートファジーを誘導する１種以上のアミノ酸を使用して１種以上の同化アミノ酸の筋骨格系への作用を増強するための組成物及び方法 | |
| WO2010041647A1 (ja) | アミノ酸組成物を有効成分として含む持久力向上剤、疲労防止剤、又は疲労回復剤 | |
| CA3011633A1 (en) | Pharmaceutical or nutritional combination comprising beta-hydroxy-betamethylbutyrate | |
| TW201836669A (zh) | 抑制肌纖維變性用組成物 | |
| Duman et al. | Bovine colostrum and its potential contributions for treatment and prevention of COVID-19 | |
| JP7410025B2 (ja) | オートファジーの誘導のために高タンパク質を使用する組成物及び方法 | |
| CN105901703A (zh) | 一种用于烧伤患者的海洋生物型肠内营养制剂 | |
| US20060204549A1 (en) | Method of improving nutrient utilisation by a mammal and a composition for use therein | |
| Gu et al. | Novel extraction technologies and potential applications of egg yolk proteins | |
| León-Sicairos et al. | Lactoferrin in the Battle against Intestinal Parasites: A | |
| ES2749749T3 (es) | Composiciones y métodos que usan aldehído tíglico | |
| TWI763916B (zh) | 藍綠藻萃取物及其製備方法與用途 | |
| JP5719116B2 (ja) | 動物由来エキスを有効成分とする、老眼、老視の改善、緩和または予防のための組成物 | |
| Sood et al. | Colostrum-miraculous fluid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA94 | Acknowledgement of application withdrawn (non-payment of fees) |
Effective date: 20170123 |